These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 2411978

  • 1. [Substances released by platelets. 1. beta-TG and PF 4].
    Niikura H.
    Rinsho Byori; 1985 Apr; Spec No 62():46-59. PubMed ID: 2411978
    [No Abstract] [Full Text] [Related]

  • 2. Detection of enhanced in vivo platelet alpha-granule release in different patient groups--comparison of beta-thromboglobulin, platelet factor 4 and thrombospondin assays.
    Lane DA, Ireland H, Wolff S, Ranasinghe E, Dawes J.
    Thromb Haemost; 1984 Oct 31; 52(2):183-7. PubMed ID: 6084323
    [Abstract] [Full Text] [Related]

  • 3. [Clinical significance of the radioimmunological determination of beta-thromboglobulin and platelet factor 4].
    Schernthaner G, Silberbauer K, Mühlhauser I, Willvonseder R.
    Acta Med Austriaca Suppl; 1979 Oct 31; 6():375-9. PubMed ID: 95543
    [Abstract] [Full Text] [Related]

  • 4. Chemistry, measurement, and clinical significance of platelet specific proteins.
    de Boer AC, Genton E, Turpie AG.
    Crit Rev Clin Lab Sci; 1982 Oct 31; 18(2):183-211. PubMed ID: 6185275
    [No Abstract] [Full Text] [Related]

  • 5. Platelet activation in myeloproliferative disorders.
    Cortelazzo S, Viero P, Barbui T.
    Thromb Haemost; 1981 Jun 30; 45(3):211-3. PubMed ID: 6169172
    [Abstract] [Full Text] [Related]

  • 6. Does the beta TG/PF4 ratio have any value in myeloproliferative diseases?
    Viero P, Cortelazzo S, Barbui T.
    Thromb Haemost; 1984 Jul 29; 51(3):411. PubMed ID: 6208631
    [No Abstract] [Full Text] [Related]

  • 7. Platelet proteins (beta-TG and PF4) in atherosclerosis and related diseases.
    Mühlhauser I, Schernthaner G, Silberbauer K, Sinzinger H, Kaliman J.
    Artery; 1980 Jul 29; 8(1):73-9. PubMed ID: 6158934
    [Abstract] [Full Text] [Related]

  • 8. Effect of aspirin on platelet 5-hydroxytryptamine and beta-thromboglobulin plasma levels in patients with myeloproliferative diseases.
    Viero P, Cortelazzo S, Bassan R, Barbui T.
    Thromb Haemost; 1982 Oct 29; 48(2):125-6. PubMed ID: 6184841
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Determination of beta-thromboglobulin (beta-TG) and platelet factor 4 (PF 4). Detection of an in vivo thrombocyte activation].
    Hellstern P, Köhler M, Wenzel E.
    ZFA (Stuttgart); 1981 May 31; 57(15):1136-41. PubMed ID: 6167083
    [No Abstract] [Full Text] [Related]

  • 13. Plasma and platelet beta-thromboglobulin in chronic myeloproliferative disorders.
    Endo Y, Mamiya S, Satoh M.
    Nihon Ketsueki Gakkai Zasshi; 1981 Feb 31; 44(1):118-23. PubMed ID: 6171982
    [No Abstract] [Full Text] [Related]

  • 14. [Selected parameters of blood platelet function in patients with myeloproliferative syndrome].
    Zuk E.
    Ann Acad Med Stetin; 1998 Feb 31; 44():137-54. PubMed ID: 9857536
    [Abstract] [Full Text] [Related]

  • 15. [Fundamental studies of a beta-thromboglobulin RIA kit].
    Kanamori I, Yabashi T, Matsuo S, Higuchi C, Baba K, Nakano S, Minakuchi K, Nomura K.
    Radioisotopes; 1983 Dec 31; 32(12):641-4. PubMed ID: 6203142
    [No Abstract] [Full Text] [Related]

  • 16. Platelet release of beta-thromboglobulin and platelet factor 4 and serotonin in plasma samples.
    Ohkawa R, Hirowatari Y, Nakamura K, Ohkubo S, Ikeda H, Okada M, Tozuka M, Nakahara K, Yatomi Y.
    Clin Biochem; 2005 Nov 31; 38(11):1023-6. PubMed ID: 16098503
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Plasma beta-thromboglobulin to platelet factor 4 ratios as indices of vascular complications in essential hypertension.
    Gomi T, Ikeda T, Yuhara M, Sakurai J, Nakayama D, Ikegami F.
    J Hypertens; 1988 May 31; 6(5):389-92. PubMed ID: 2968397
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.